Ginsenoside Rg2 inhibits osteoclastogenesis by downregulating the NFATc1, c-Fos, and MAPK pathways

Ginsenosides, among the most active components of ginseng, exhibit several therapeutic effects against cancer, diabetes, and other metabolic diseases. However, the molecular mechanism underlying the anti-osteoporotic activity of ginsenoside Rg2, a major ginsenoside, has not been clearly elucidated....

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sung-Hoon, Park, Shin-Young, Kim, Jung Ha, Kim, Nacksung, Lee, Junwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618073/
https://www.ncbi.nlm.nih.gov/pubmed/37605614
http://dx.doi.org/10.5483/BMBRep.2023-0100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618073/
https://www.ncbi.nlm.nih.gov/pubmed/37605614
http://dx.doi.org/10.5483/BMBRep.2023-0100

Ejemplares similares